How can Modelling and Simulation Fuel the Clinical Development of Biosimilars?
The relatively low cost to enter the “generic” market and the size of the biologic drug market make entry attractive.…
Read more
Health Informatics Data: Connecting Patients to Investigators
From the perspective of a clinical trial, a rare disease suggests the available patient and site population is quite small…
Everything Old is New Again: Bacteriophage Therapy
Bacteriophages are viruses that can be found inside plants and animals and in soil, rivers, oceans, and even sewers. Phages…
Patient-Centricity – a Winning Formula
There has been considerable discussion around the concept of patientcentricity in the pharmaceutical community. The industry has taken a collective…
Clinical Precision: What does AI Offer Life Sciences?
Where information overload has started to slow innovation and efficiency in medicinal markets, could artificial intelligence and machine learning help…
Big Data’s Role in Patient-centric Care
The healthcare industry needs a fully connected IT infrastructure, integrating information from multiple systems to ease administrative workloads, facilitate patient-provider…
Doing More with Clinical Trial Business Data: Adopt a Data Warehouse
Pharmaceutical companies have been working for years on leveraging their clinical research data in more efficient ways, but other sectors…
How Functional Service Provision can Directly Impact Clinical Trials Success – Crucial Factors to Select the Right Model
In this paper, Chris Hamilton, Chief Commercial Officer at CROS NT, analyses how it is important to delve into the…
Rise of Paediatric Diabetes in Mauritius
In this paper, Laure Lam Hung PhD, Project Manager and Clinical Research Associate at CIDP and Dr Tarkeswarnath Bachoo MBBS,…
Panel Recommends Device While Questioning Clinical Trial Change
The US Food and Drug Administration (FDA) allows for some flexibility related to changes in clinical trial protocols—for example, with…